REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apatfalva Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: APATFALVA Gyogyszereszeti es Kereskedelmi Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Apatfalva Bt. is based in Hungary, with the head office in Apatfalva. It operates in the Pharmacies and Drug Stores industry. The company was established on August 28, 1995. There are currently 4 (2023) people employed by Apatfalva Bt.. In 2022, the company reported a net sales revenue increase of 8.53%. Its’ total assets recorded a growth of 23.01%. Apatfalva Bt.’s net profit margin decreased by 1.08% in 2022.

Headquarters
Hunyadi u. 6.
Apatfalva; Csongrad; Postal Code: 6931

Contact Details: Purchase the Apatfalva Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Apatfalva Bt. report to view the information.
Outstanding Shares:
Purchase the Apatfalva Bt. report to view the information.
Registered Capital:
Purchase the Apatfalva Bt. report to view the information.
Financial Auditors:
Purchase the Apatfalva Bt. report to view the information.
Incorporation Date:
August 28, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Apatfalva Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.53%▲
Total operating revenue
8.27%▲
Operating profit (EBIT)
-2.34%▼
EBITDA
-2.38%▼
Net Profit (Loss) for the Period
-38.69%▼
Total assets
23.01%▲
Total equity
32.81%▲
Operating Profit Margin (ROS)
-0.18%▼
Net Profit Margin
-1.08%▼
Return on Equity (ROE)
-28.81%▼
Quick Ratio
0.13%▲
Cash Ratio
0.19%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo